Limosilactobacillus mucosae FZJTZ26M3 prevents NAFLD in mice through modulation of lipid metabolism and gut microbiota dysbiosis

Limosilactobacillus mucosae FZJTZ26M3 prevents NAFLD in mice through modulation of lipid metabolism and gut microbiota dysbiosis

Lactobacillus are considered promising therapeutic methods for nonalcoholic fatty liver disease (NAFLD). The effects of two strains of Limosilactobacillus mucosae on NAFLD were investigated in this study. Four-week-old male C57BL/6J mice were divided into 4 groups (n = 8 per group, Control, Model, F...

Full description

Saved in:
Bibliographic Details
Main Authors: Danting Dang, Bowen Li, Mengfan Ding, R. Paul Ross, Catherine Stanton, Jianxin Zhao, Bo Yang, Wei Chen
Format: Article
Language:English
Published: Tsinghua University Press 2024-05-01
Series:Food Science and Human Wellness
Subjects:
limosilactobacillus mucosae
nonalcoholic fatty liver disease (nafld)
probiotic
lipid metabolism
gut microbiota
Online Access:https://www.sciopen.com/article/10.26599/FSHW.2022.9250134
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.sciopen.com/article/10.26599/FSHW.2022.9250134

Similar Items